Concepedia

James Neiswender

JN

Statistics

Publications

6

Citations

1K

H-Index

6

Active since

2011

Affiliations

University of Massachusetts Chan Medical School(Current)

Howard Hughes Medical Institute

James Neiswender is an author at University of Massachusetts Chan Medical School specializing in oncology, molecular oncology, and molecular biology.

Publications per year

2011–2024

6

Publications

6

Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma

Christine G. Lian, Yufei Xu, Craig J. Ceol et al. · Cell · 2012 · 805 citations · Full text

Medicine, Molecular Biology, Oncology +14

Production of the antifungal compounds phenazine and pyrrolnitrin from Pseudomonas chlororaphis O6 is differentially regulated by glucose

J.Y. Park, Sang A Oh, Anne J. Anderson et al. · Letters in Applied Microbiology · 2011 · 95 citations

Agriculture, Microbiology, Plant Sciences +16

Intracranial <scp>AAV</scp>‐<scp>IFN</scp>‐β gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model

Dwijit GuhaSarkar, James Neiswender, Qin Su et al. · Molecular Oncology · 2017 · 53 citations · Full text

Medicine, Molecular Biology, Oncology +17

CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13

Jean C. Tien, Jie Luo, Yu Chang et al. · Cell Reports Medicine · 2024 · 28 citations · Full text

Medicine, Molecular Biology, Oncology +16

KIT Suppresses BRAFV600E-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling

James Neiswender, Robert L. Kortum, Caitlin Bourque et al. · Cancer Research · 2017 · 20 citations · Full text

Life Sciences, Genetics, Oncology +17

1–5 of 6